GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AtriCure Inc (NAS:ATRC) » Definitions » Shiller PE Ratio

AtriCure (AtriCure) Shiller PE Ratio

: (As of Today)
View and export this data going back to 2005. Start your Free Trial

Shiller PE for Stocks: The True Measure of Stock Valuation


AtriCure Shiller PE Ratio Historical Data

The historical data trend for AtriCure's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AtriCure Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

AtriCure Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison

For the Medical Instruments & Supplies subindustry, AtriCure's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AtriCure Shiller PE Ratio Distribution

For the Medical Devices & Instruments industry and Healthcare sector, AtriCure's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where AtriCure's Shiller PE Ratio falls into.



AtriCure Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

AtriCure's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, AtriCure's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0.21/129.4194*129.4194
=-0.210

Current CPI (Dec. 2023) = 129.4194.

AtriCure Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 -0.310 99.695 -0.402
201406 -0.100 100.560 -0.129
201409 -0.020 100.428 -0.026
201412 -0.200 99.070 -0.261
201503 -0.190 99.621 -0.247
201506 -0.180 100.684 -0.231
201509 -0.220 100.392 -0.284
201512 -0.360 99.792 -0.467
201603 -0.310 100.470 -0.399
201606 -0.260 101.688 -0.331
201609 -0.210 101.861 -0.267
201612 -0.270 101.863 -0.343
201703 -0.320 102.862 -0.403
201706 -0.210 103.349 -0.263
201709 -0.220 104.136 -0.273
201712 -0.080 104.011 -0.100
201803 -0.310 105.290 -0.381
201806 -0.010 106.317 -0.012
201809 -0.220 106.507 -0.267
201812 -0.090 105.998 -0.110
201903 -0.150 107.251 -0.181
201906 -0.110 108.070 -0.132
201909 -0.250 108.329 -0.299
201912 -0.420 108.420 -0.501
202003 -0.420 108.902 -0.499
202006 -0.200 108.767 -0.238
202009 -0.110 109.815 -0.130
202012 -0.420 109.897 -0.495
202103 -0.380 111.754 -0.440
202106 -0.360 114.631 -0.406
202109 2.110 115.734 2.359
202112 -0.300 117.630 -0.330
202203 -0.330 121.301 -0.352
202206 -0.320 125.017 -0.331
202209 -0.270 125.227 -0.279
202212 -0.090 125.222 -0.093
202303 -0.140 127.348 -0.142
202306 -0.110 128.729 -0.111
202309 -0.200 129.860 -0.199
202312 -0.210 129.419 -0.210

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


AtriCure  (NAS:ATRC) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


AtriCure Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of AtriCure's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


AtriCure (AtriCure) Business Description

Traded in Other Exchanges
N/A
Address
7555 Innovation Way, Mason, OH, USA, 45040
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.
Executives
Karl S. Dahlquist officer: Chief Legal Officer 7555 INNOVATION WAY, MASON OH 45040
Karen Prange director 1108 S RIO VISTA BLVD, FORT LAUDERDALE FL 33316
Maggie Yuen director ONE PENUMBRA PLACE, ALAMEDA CA 94502
Vinayak Doraiswamy officer: Chief Scientific Officer 7555 INNOVATION WAY, MASON OH 45040
Deborah Lee Yount officer: Chief Human Resources Officer 7555 INNOVATION WAY, MASON OH 45040
Tonya Austin officer: Chief Human Resources Officer 7555 INNOVATION WAY, MASON OH 45040
Angela L Wirick officer: Chief Financial Officer 7555 INNOVATION WAY, MASON OH 45040
Mark A Collar director 382 BISHOPBRIDGE DR, CINCINNATI OH 45255
Regina E Groves director 5751 COPLEY DRIVE, SAN DIEGO CA 92111
Douglas J Seith officer: SVP of Sales and Marketing 7555 INNOVATION WAY, MASON OH 45040
Salvatore Privitera officer: VP; Product Development 7555 INNOVATION WAY, MASON OH 45040
Justin J Noznesky officer: SVP, Mktg & Business Develop 7555 INNOVATION WAY, MASON OH 45040
Deborah H Telman director 2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033
Scott William Drake director 9965 FEDERAL DRIVE, COLORADO SPRINGS CO 80921
Sven Wehrwein director